Sort by:
- Doctors (12)
- Locations (14)
Cristina Bostan
Contact Info
Office Hours
- Today
- 8:00AM - 4:00PM
Cristina Bostan
About Cristina Bostan
Dr. Cristina Bostan completed the combined Doctor of Medicine and Master of Science program, followed by Ophthalmology residency training on the Clinician-Investigator track at the Université de Montréal. She served as Chief Resident and was named to the Dean’s list upon graduation from her residency program. She went on to pursue a one-year clinical and surgical fellowship in Cornea, External Disease and Refractive Surgery at the Cole Eye Institute of the world-renowned Cleveland Clinic, where she gained expertise in the management of the entire spectrum of corneal conditions and performed high-volumes of ocular surface procedures, corneal transplantations, complex anterior segment, cataract and lens-based procedures. Dr Bostan additionally pursued a one-year research fellowship in corneal disease and is currently finalizing a Master in Translational Research at the prestigious University of Toronto.
Dr. Bostan is now a Cornea, External Disease, Cataract/Anterior Segment and Refractive Surgery specialist at the Centre universitaire d'ophtalmologie de l'Université de Montréal at the Maisonneuve-Rosemont Hospital and an Assistant Clinical Professor of Ophthalmology at Université de Montréal. In this role, she supervises medical students, ophthalmology residents, and cornea fellows. She is also actively involved in research, with the overarching goal of accelerating the speed at which emerging therapies reach her patients. Her research work has received numerous awards and grants - including from provincial and national major granting agencies - and has been the subject of over 100 publications and presentations locally and internationally.
In her clinical work, Dr. Bostan values patient partnership and patient satisfaction above all, and aims to provide the highest-quality, up-to-date care to every patient.
Select Your Region
Latin America
References
1. Patient Survey, STAAR Surgical ICL Data Registry, 2018
2. Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46. Patient Survey, STAAR Surgical ICL Data Registry, 2018
3. Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.
5a. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.
5b. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.
Important Safety Information
The EVO/EVO+ ICLs are indicated for patients who are 21 to 60 years of age and are available in spherical powers ranging from -3.0 D to -18.0 D for the correction/reduction of myopia with or without a cylinder power range from 1.0 D to 6.0 D. The hyperopic ICLs are indicated for patients who are 21 to 45 years of age and are available in powers ranging from +3.0 D to +10.0 D for the correction/reduction of hyperopia. In order to be sure that your surgeon will use an ICL with the most adequate power for your eye, your nearsightedness, farsightedness and astigmatism should be stable for at least a year before undergoing eye surgery. ICL surgery may improve your vision without eyeglasses or contact lenses. ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct your vision such as contact lenses and eye glasses. Implantation of an ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/ adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctiva I irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering ICL surgery you should have a complete eye examination and talk with your eye care professional about ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.